GO:1905242 response to 3,3',5-triiodo-L-thyronine: Thyroid Hormone Signaling, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905242 describes any cellular or organismal process that changes in response to the thyroid hormone 3,3',5-triiodo-L-thyronine (T3).
• T3 response is tissue-specific and age-dependent, with reduced sensitivity in aging and in thyroid hormone resistance syndromes.
• T3 rapidly modulates hepatic signaling pathways, including protein kinase C-sensitive and Ca2+-independent branches of alpha1-adrenoreceptor signaling.
• In zebrafish embryos, T3 exposure alters expression dynamics of hypothalamic-pituitary-thyroid (HPT) cascade genes, highlighting endocrine disruption risks.
• T3 influences cardiac contractility and beta-adrenergic responsiveness in dilated cardiomyopathy.
• T3 crosstalk with macrophages is an emerging area in immunity and inflammation.
Description
GO:1905242, response to 3,3',5-triiodo-L-thyronine, is a biological process term that captures any change in cellular or organismal state or activity following exposure to the active thyroid hormone T3. This includes alterations in gene expression, enzyme production, secretion, movement, and other physiological outputs. T3 is a critical regulator of development, metabolism, and homeostasis, and its effects are mediated through nuclear thyroid hormone receptors and non-genomic pathways. Understanding this response is essential for researchers studying endocrine signaling, metabolic disease, and developmental biology. The term is particularly relevant because T3 responsiveness varies by tissue, age, and pathophysiological context, as seen in age-related resistance to thyroid hormone action and in children with thyroid hormone resistance. Moreover, T3 rapidly regulates hepatic signaling cascades, such as protein kinase C-sensitive branches of alpha1-adrenoreceptor signaling, demonstrating the complexity of the response beyond classical gene regulation. In zebrafish embryo-larvae, T3 exposure dynamically alters the expression of genes in the hypothalamic-pituitary-thyroid cascade, underscoring the environmental sensitivity of this process. These examples illustrate why GO:1905242 is a key term for annotating and interpreting thyroid hormone biology across species.
response to 3,3',5-triiodo-L-thyronine At A Glance
| GO ID | GO:1905242 |
|---|---|
| GO term | response to 3,3',5-triiodo-L-thyronine |
| Ontology | biological_process |
| Synonym | response to Liothyronin, response to Liothyronine, response to Liothyroninum |
| Major function | Mediates cellular and organismal changes triggered by the thyroid hormone T3, including gene expression, enzyme production, and secretion. |
| Taxonomic range | Eukaryotes, including human, rodent, chicken, and zebrafish. |
| Related pathways | Thyroid hormone signaling, hypothalamic-pituitary-thyroid axis, adrenergic signaling. |
| Disease relevance | Thyroid hormone resistance, age-related hormone resistance, cardiomyopathy, metabolic disorders. |
What Is GO:1905242?
GO:1905242 is defined as any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a 3,3',5-triiodo-L-thyronine stimulus. In simpler terms, it encompasses all the ways a biological system responds to the active thyroid hormone T3, from rapid signaling events to long-term changes in gene expression and physiology.
Why Is response to 3,3',5-triiodo-L-thyronine Important in Cell Biology?
GO:1905242 is important because T3 is a master regulator of development, metabolism, and cardiovascular function, and its response pathways are implicated in a wide range of physiological and pathological states. Disrupted T3 responses contribute to age-related hormone resistance, pediatric thyroid hormone resistance, and altered cardiac contractility in heart failure. Additionally, T3 modulates immune cell function, such as macrophages, linking thyroid signaling to inflammation and immunity. In ecotoxicology, T3-responsive gene expression in zebrafish serves as a sensitive endpoint for thyroid-disrupting chemicals. Thus, studying this process helps elucidate fundamental biology and provides translational insights for endocrine, metabolic, and cardiovascular diseases.
• T3 response is central to metabolic regulation, influencing hepatic protein synthesis and enzyme production.
• Age-related resistance to thyroid hormone action alters T3 responsiveness in older adults, affecting drug efficacy and disease risk.
• In children, thyroid hormone resistance syndromes can lead to growth and developmental abnormalities.
• T3 acutely regulates cardiac myocyte contractility and beta-adrenergic responsiveness, with implications for dilated cardiomyopathy.
• T3 modulates macrophage function, bridging endocrine and immune systems.
• Zebrafish HPT cascade genes respond to T3, providing a model for endocrine disruption screening.
• T3 supplementation alters insulin-like growth factor-I concentrations in a tissue-specific manner in dwarf chickens.
• T3 rapidly activates protein kinase C-sensitive signaling in hepatocytes, independent of Ca2+.
• Understanding T3 response aids in designing therapies for thyroid disorders and metabolic syndrome.
• GO:1905242 annotations support functional genomics and CRISPR screening for thyroid hormone pathway components.
What Happens During response to 3,3',5-triiodo-L-thyronine?
T3 Entry and Receptor Binding
In simple terms: T3 enters cells and binds to thyroid hormone receptors to initiate a response.
T3, the active form of thyroid hormone, is transported into cells and binds to nuclear thyroid hormone receptors (TRs), which act as ligand-dependent transcription factors. This binding triggers conformational changes that allow TRs to regulate target gene expression. In addition to nuclear actions, T3 can also interact with membrane receptors to initiate rapid non-genomic signaling.
Rapid Non-Genomic Signaling
In simple terms: T3 can trigger fast cellular signals without changing gene expression.
T3 acutely regulates a protein kinase C-sensitive, Ca2+-independent branch of the hepatic alpha1-adrenoreceptor signaling pathway, demonstrating rapid non-genomic effects. Such signaling events can modulate enzyme activity, ion channels, and contractility within minutes, as observed in cardiac myocytes where T3 enhances beta-adrenergic responsiveness.
Transcriptional Regulation of Target Genes
In simple terms: T3 changes which genes are turned on or off.
Upon binding to TRs, T3 modulates the transcription of numerous target genes involved in metabolism, growth, and development. For example, in zebrafish embryo-larvae, T3 exposure alters the expression dynamics of genes in the hypothalamic-pituitary-thyroid (HPT) cascade. In diabetic rats, T3 influences the synthesis of hepatic proteins, and in growth hormone receptor-deficient chickens, T3 supplementation tissue-specifically alters insulin-like growth factor-I concentrations.
Tissue-Specific and Age-Dependent Responses
In simple terms: Different tissues and ages respond to T3 differently.
The response to T3 is not uniform; it varies by tissue and age. Age-related resistance to thyroid hormone action reduces T3 sensitivity in older individuals. In children, thyroid hormone resistance syndromes manifest with variable tissue responsiveness. Tissue-specific effects are also evident in the differential regulation of IGF-I in chickens and in the heart, where T3 affects contractile function in dilated cardiomyopathy.
Integration with Immune and Endocrine Systems
In simple terms: T3 also talks to the immune system.
T3 interacts with macrophages, influencing their function and inflammatory responses. This crosstalk highlights the broader role of T3 response in integrating endocrine and immune signals, which is relevant for understanding diseases with inflammatory components.
Key Genes Involved in GO:1905242 response to 3,3',5-triiodo-L-thyronine
The following genes and proteins are key players in the response to 3,3',5-triiodo-L-thyronine (T3), based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| THRA | Thyroid hormone receptor alpha; mediates T3-dependent transcription | Mutations cause thyroid hormone resistance; target for metabolic studies |
| THRB | Thyroid hormone receptor beta; mediates T3-dependent transcription | Mutations cause thyroid hormone resistance; key for cardiac and hepatic T3 effects |
| DIO1 | Deiodinase 1; converts T4 to T3 | Regulates local T3 availability; altered in thyroid dysfunction |
| DIO2 | Deiodinase 2; converts T4 to T3 | Important for local T3 production in brain and pituitary |
| DIO3 | Deiodinase 3; inactivates T3 and T4 | Protects tissues from excess T3; developmental roles |
| TSHB | Thyroid stimulating hormone beta subunit | Part of HPT axis; responds to T3 feedback |
| TRH | Thyrotropin-releasing hormone | Hypothalamic regulator of TSH; T3-responsive |
| IGF1 | Insulin-like growth factor I | T3 alters IGF-I levels tissue-specifically |
| ADRA1A | Alpha1-adrenergic receptor | T3 modulates its signaling in liver |
| PRKCA | Protein kinase C alpha | Involved in T3 rapid signaling |
| MYH7 | Myosin heavy chain 7 | T3 regulates cardiac contractility genes |
| ATP2A2 | SERCA2 calcium pump | T3 affects calcium handling in cardiomyocytes |
| TNF | Tumor necrosis factor | T3 modulates macrophage cytokine production |
| IL6 | Interleukin 6 | T3 influences inflammatory cytokine release |
| AKT1 | Protein kinase B | T3 can activate PI3K/AKT pathway in some tissues |
| MAPK1 | Mitogen-activated protein kinase 1 | T3 activates MAPK signaling in non-genomic responses |
| STAT3 | Signal transducer and activator of transcription 3 | T3 crosstalk with cytokine signaling |
| NFKB1 | Nuclear factor kappa B subunit 1 | T3 modulates NF-kB activity in inflammation |
How Is response to 3,3',5-triiodo-L-thyronine Regulated?
The response to T3 is regulated at multiple levels. Circulating T3 levels are controlled by the hypothalamic-pituitary-thyroid (HPT) axis, where TRH and TSH are subject to negative feedback by T3. Local T3 availability is regulated by deiodinases (DIO1, DIO2, DIO3) that activate or inactivate thyroid hormones. At the cellular level, thyroid hormone receptors (THRA, THRB) and their coregulators modulate transcriptional responses. Additionally, age-related factors can induce resistance to thyroid hormone action, reducing responsiveness in older tissues. Rapid non-genomic signaling pathways, such as PKC and MAPK, also contribute to T3 response regulation.
response to 3,3',5-triiodo-L-thyronine and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| THRA | Thyroid hormone resistance, metabolic dysfunction | Knock-in of patient mutations in cell lines; KO mice |
| THRB | Thyroid hormone resistance, cardiac dysfunction | Point mutation knock-in models; cardiomyocyte KO |
| DIO2 | Impaired local T3 production, neurodevelopmental disorders | Overexpression and KO in neuronal cells |
| IGF1 | Growth retardation, tissue-specific T3 resistance | Tissue-specific KO in chicken or mouse |
| TNF | Inflammatory diseases, macrophage dysfunction | Macrophage-specific KO; overexpression |
Thyroid Hormone Resistance Syndromes
Mutations in THRA or THRB cause resistance to thyroid hormone (RTH), characterized by reduced tissue responsiveness to T3. In children, RTH can lead to growth retardation, goiter, and metabolic abnormalities. Age-related resistance to thyroid hormone action further complicates diagnosis and management in older adults.
Cardiovascular Disease
T3 exerts profound effects on cardiac function. In dilated cardiomyopathy, T3 enhances myocyte contractile function and beta-adrenergic responsiveness, suggesting potential therapeutic roles. Altered T3 signaling is associated with heart failure progression and arrhythmias.
Metabolic and Immune Disorders
T3 regulates hepatic protein synthesis and glucose metabolism, and its dysfunction contributes to metabolic syndrome. T3 also modulates macrophage function and cytokine production, linking thyroid status to inflammatory diseases.
Endocrine Disruption
Environmental chemicals can interfere with T3 signaling, as shown in zebrafish where T3-responsive HPT genes are altered by thyroid-disrupting chemicals. This has implications for developmental toxicity and ecological risk assessment.
From response to 3,3',5-triiodo-L-thyronine-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does THRA mutation alter T3-dependent transcription? | Point mutation knock-in in HEK293 or HepG2 cells |
| What is the role of DIO2 in local T3 availability? | Knockout and overexpression in neuronal cell lines |
| How does T3 affect cardiac contractility? | Cardiomyocyte-specific THRB knockout or overexpression |
| Which genes are direct T3 targets in macrophages? | CRISPR knockout of THRA/THRB in macrophage cell lines followed by RNA-seq |
| Can T3 response be modulated by environmental chemicals? | Zebrafish embryo-larvae exposed to T3 and chemicals, with HPT gene expression readout |
| What is the impact of age-related T3 resistance? | Aged mouse models with tissue-specific KO of THRA/THRB |
How to Study the response to 3,3',5-triiodo-L-thyronine Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify T3-responsive genes in tissues or cell lines |
| Proteomics | Protein abundance and modifications | Discover non-genomic T3 signaling effectors |
| Phosphoproteomics | Phosphorylation events | Map rapid T3 signaling pathways |
| Luciferase reporter assay | TRE-driven transcription | Quantify T3 potency and receptor activity |
| CRISPR knockout screen | Gene function in T3 response | Identify novel regulators of T3 signaling |
| ChIP-seq | TR binding sites on chromatin | Map direct T3 target genes |
| Live-cell imaging | Protein localization and dynamics | Visualize TR translocation and signaling |
| Zebrafish HPT gene expression | In vivo endocrine disruption | Screen chemicals for T3-like or anti-thyroid activity |
Transcriptomic Profiling
RNA-seq after T3 stimulation can identify global changes in gene expression, as demonstrated in zebrafish HPT cascade studies. This method reveals both direct and indirect T3-responsive genes and can be combined with CRISPR knockout of candidate regulators.
Proteomic and Phosphoproteomic Analysis
Mass spectrometry-based proteomics can quantify T3-induced changes in protein abundance and phosphorylation, uncovering non-genomic signaling events such as PKC and MAPK activation. This is useful for studying rapid responses.
Reporter Assays and Imaging
Luciferase reporters driven by thyroid hormone response elements (TREs) can measure T3-dependent transcriptional activity. Live-cell imaging of fluorescently tagged TRs or signaling molecules can visualize translocation and interactions in real time.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify genes that modulate T3 response. For example, screening for regulators of T3-induced gene expression in hepatocytes or macrophages can reveal novel therapeutic targets.
How CRISPR Can Be Used to Study GO:1905242 response to 3,3',5-triiodo-L-thyronine
Knockout
CRISPR knockout of THRA, THRB, or DIO genes in cell lines can abolish T3 responsiveness, allowing researchers to study loss-of-function phenotypes. For example, THRA knockout in hepatocytes can reveal its role in T3-regulated hepatic protein synthesis.
Point Mutation
Introducing patient-derived point mutations in THRA or THRB via CRISPR base editing or HDR can model thyroid hormone resistance syndromes. These models help dissect dominant-negative effects and tissue-specific resistance.
Knock-in
Knock-in of tagged TRs (e.g., GFP-THRA) enables live-cell imaging and ChIP-seq to map T3-dependent chromatin binding. Knock-in of TRE-driven reporters can quantify T3 response in vivo.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of THRA, THRB, or DIO2 can enhance T3 sensitivity, useful for studying gain-of-function and for screening compounds that modulate T3 response.
How EDITGENE Supports response to 3,3',5-triiodo-L-thyronine Research
Researchers studying response to 3,3',5-triiodo-L-thyronine-related genes often need to determine whether a candidate gene is causally involved in T3 signaling, metabolic regulation, or disease. EDITGENE provides comprehensive CRISPR-based services to create precise cellular and animal models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for response to 3,3',5-triiodo-L-thyronine research.
Frequently Asked Questions About response to 3,3',5-triiodo-L-thyronine
What is GO:1905242?
GO:1905242 is a Gene Ontology biological process term for any process that results in a change in state or activity of a cell or organism as a result of a 3,3',5-triiodo-L-thyronine (T3) stimulus.
What genes are involved in response to 3,3',5-triiodo-L-thyronine?
Key genes include THRA, THRB, DIO1, DIO2, DIO3, TSHB, TRH, IGF1, and inflammatory genes such as TNF and IL6.
How does T3 trigger cellular responses?
T3 binds to nuclear thyroid hormone receptors to regulate transcription and also activates rapid non-genomic signaling pathways such as PKC and MAPK.
What diseases are associated with altered T3 response?
Thyroid hormone resistance syndromes, age-related hormone resistance, cardiovascular disease, and metabolic disorders are linked to altered T3 response.
Can CRISPR be used to study T3 response?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can dissect the roles of specific genes in T3 signaling.
What model organisms are used for T3 response research?
Zebrafish, rodents, chickens, and cell lines such as hepatocytes and cardiomyocytes are commonly used.
How is T3 response measured experimentally?
Methods include RNA-seq, proteomics, luciferase reporter assays, ChIP-seq, and live-cell imaging.
What is the role of deiodinases in T3 response?
Deiodinases DIO1 and DIO2 convert T4 to active T3, while DIO3 inactivates thyroid hormones, thereby regulating local T3 availability.
Is T3 response tissue-specific?
Yes, T3 effects vary by tissue; for example, IGF-I levels change differently across tissues in chickens, and cardiac and hepatic responses differ.
How does aging affect T3 response?
Aging can lead to resistance to thyroid hormone action, reducing T3 sensitivity in older individuals.
Conclusion
GO:1905242, response to 3,3',5-triiodo-L-thyronine, encapsulates the diverse cellular and organismal changes triggered by the active thyroid hormone T3. From rapid non-genomic signaling to long-term transcriptional regulation, this process is vital for metabolism, development, and cardiovascular function. Dysregulation contributes to thyroid hormone resistance, heart disease, and metabolic disorders. Leveraging CRISPR-based models and multi-omics approaches will continue to unravel the complexities of T3 response and inform therapeutic strategies.
References
- 1. Mooradian AD. 2019. Age-Related Resistance to Thyroid Hormone Action.. Drugs Aging 36(11):1007-1014 PMID: 31512083
- 2. Parsons AE et al.. 2020. Expression dynamics of genes in the hypothalamic-pituitary-thyroid (HPT) cascade and their responses to 3,3',5-triiodo-l-thyronine (T3) highlights potential vulnerability to thyroid-disrupting chemicals in zebrafish (Danio rerio) embryo-larvae.. Aquat Toxicol 225:105547 PMID: 32623180
- 3. Takeda T et al.. 1994. Response of hepatic proteins to 3,5,3'-tri-iodo-L-thyronine in diabetic rats.. J Endocrinol 143(1):55-63 PMID: 7964322
- 4. Vasilatos-Younken R et al.. 1997. Tissue-specific alterations in insulin-like growth factor-I concentrations in response to 3,3',5-triiodo-L-thyronine supplementation in the growth hormone receptor-deficient sex-linked dwarf chicken.. Gen Comp Endocrinol 105(1):31-9 PMID: 9000465
- 5. Ercan O. 2003. Thyroid Hormone Resistance in children.. Pediatr Endocrinol Rev 1 Suppl 2:191-8; discussion 198 PMID: 16444158
- 6. Walker JD et al.. 1994. The novel effects of 3,5,3'-triiodo-L-thyronine on myocyte contractile function and beta-adrenergic responsiveness in dilated cardiomyopathy.. J Thorac Cardiovasc Surg 108(4):672-9 PMID: 7934101
- 7. Yang L et al.. 2024. Research Advancements in the Interplay between T3 and Macrophages.. Curr Med Sci 44(5):883-889 PMID: 39446284
- 8. Daza FJ et al.. 1998. 3,5,3'-Tri-iodo-L-thyronine acutely regulates a protein kinase C-sensitive, Ca2+-independent, branch of the hepatic alpha1-adrenoreceptor signalling pathway.. Biochem J 331 ( Pt 1)(Pt 1):89-97 PMID: 9512465
